Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 12, 2026
Economic evaluation of perioperative pembrolizumab plus standard of care as treatment for resectable locally advanced head and neck squamous cell carcinoma in the United States.
Journal: Journal of medical economics
Published: February 23, 2026
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Journal: The New England journal of medicine
Published: June 18, 2025
Radiotherapy and Immunotherapy Combinations for Lung Cancer.
Journal: Current oncology reports
Published: November 05, 2020
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation.
Journal: Advances in radiation oncology
Published: August 20, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026